Viridans streptococci

Associated infections

• Infective endocarditis on native and prosthetic valves
• Bacteraemia in neutropenic and haematology-oncology patients
• Viridans streptococcal shock syndrome
• Dental caries and periapical infection
• Brain, liver and intra-abdominal abscess (anginosus group)
• Empyema and pleural infection
• Odontogenic and head-and-neck deep space infection
• Bacteraemia associated with colonic neoplasia (bovis/gallolyticus group)

Transmission route

Infection with viridans streptococci is overwhelmingly endogenous. Organisms already colonising the oral cavity enter the bloodstream during invasive dental procedures such as extraction and subgingival scaling, and transient bacteraemia also follows ordinary activities including tooth brushing, flossing and chewing. Because those everyday events occur many times a day and dental procedures occur rarely, cumulative exposure from normal oral activity is now considered to outweigh procedural exposure in most patients, which is the reasoning behind the narrowing of antibiotic prophylaxis recommendations to the highest-risk cardiac groups.

In patients with structural valve disease, prosthetic valves or intravascular devices, repeated low-grade seeding is the basis of subacute infective endocarditis, with the organism establishing on a platelet-fibrin nidus at an area of endothelial damage. In neutropenic patients, chemotherapy-induced oral mucositis provides a portal of entry for a large inoculum at a time when the host has minimal capacity to clear it, and the resulting bacteraemia can progress within hours to a shock syndrome with acute respiratory distress. Poor oral hygiene, gingival inflammation and untreated dental disease increase the burden of organisms available to translocate in both settings.

There is no meaningful person-to-person or environmental transmission route in the healthcare setting. Viridans streptococci are fastidious and host-adapted, and they neither survive well nor multiply in treated water. They are not constituents of premise-plumbing biofilm and are not organisms that reverse osmosis or ultrafiltration systems are designed to control, because they are not expected to be present. Their oral abundance nonetheless makes them one of the more common incidental contaminants in any sampling activity performed by a person speaking or breathing over an open vessel, which is central to how their recovery from water should be interpreted.

Relevance in endoscopy and reprocessing

There is no documented transmission of viridans streptococcal infection through endoscope reprocessing water, and these organisms do not feature in the endoscopy outbreak literature as waterborne agents. They are, however, among the organisms most consistently recovered from inadequately cleaned upper gastrointestinal endoscopes, because they are present in very large numbers in the material that passes through the suction and biopsy channels during gastroscopy. Their recovery from a channel sample is therefore best read as a marker of residual patient-derived bioburden.

That has direct implications for reprocessing practice. Oral streptococci are embedded in a salivary and mucous matrix that is viscous, adheres to channel walls and dries rapidly if pre-cleaning at the point of use is delayed. Once dried, it is markedly harder to remove and it shields organisms from subsequent disinfectant contact. The controls that matter are bedside pre-cleaning immediately after the procedure, prompt transport to the reprocessing room, leak testing, and thorough manual cleaning with correctly sized brushes through every channel including elevator and auxiliary channels on duodenoscopes and linear echoendoscopes. Where a facility uses protein or adenosine triphosphate residue testing as a cleaning-verification step, a viridans isolate is a useful corroborating signal that those checks warrant review.

Against high-level disinfection itself these organisms present no challenge. They are vegetative, non-sporing and have no unusual biocide tolerance; glutaraldehyde, ortho-phthalaldehyde and peracetic acid at their validated contact conditions inactivate them reliably, as do the thermal processes used in CSD. They form no durable biofilm in purified water lines. The residual risk lies in drying and storage: a scope that retains moisture and residual organic material in a channel can support regrowth of a mixed flora during storage, and inadequate drying is a recognised failure point in Australian and international reprocessing audits. In dental practice the same organisms are the principal biological content of the aerosol and backflow load on dental unit waterlines, and their presence in a waterline sample points to retraction or backflow control and line disinfection rather than to the incoming water supply.

Interpreting a detection

Recovery of viridans streptococci from automated endoscope reprocessor final rinse water is not a water-quality finding in the usual sense, and treating it as one leads facilities to investigate the wrong system. The realistic explanations are contamination of the sample by the operator's own oral flora during collection, contamination of the sampling port or vessel, or carry-over of patient-derived oral or upper gastrointestinal material within the reprocessor circuit or endoscope channels. A fourth possibility, laboratory contamination or misidentification, should not be discounted where the report is at group level only.

The first checks are on the sample rather than the plant. Establish whether the collector wore a mask and avoided speaking over the open container, whether the port was disinfected and flushed for the specified time and volume, whether the container was opened only at the moment of filling, and whether hold time and temperature to the laboratory were within specification. Review the total viable count and any co-isolates from the same sample. A single low-count viridans isolate in a sample that is otherwise fully compliant, with no Gram-negative organisms and a normal count, is far more consistent with touch or aerosol contamination at collection than with a system fault. Repeat sampling under strict aseptic technique, ideally by a different trained collector, will resolve most of these.

A trend carries different weight. Repeated recovery across successive sampling rounds, recovery from more than one reprocessor or outlet, high counts, or recovery alongside an elevated total viable count or a Gram-negative co-isolate suggests a genuine pathway rather than an artefact. In that case the review should cover manual cleaning and brushing records and competency, the reprocessor self-disinfection cycle and its verification, the condition and change interval of terminal filters, the integrity of connectors and channel adaptors, and the post-rinse drying and storage pathway. Escalation to infection prevention is warranted where the pattern persists after sampling technique has been corrected and verified, where counts are rising, or where a patient infection with a matching organism has been identified. Pending resolution in those circumstances, the affected reprocessor and the instruments processed through it should be quarantined and the scope release process suspended.

Antimicrobial resistance

Penicillin non-susceptibility among viridans streptococci is well recognised and is mediated by altered penicillin-binding proteins rather than beta-lactamase, with the mitis group generally showing the highest rates. The mechanism arises through recombination with penicillin-binding protein gene fragments acquired from related oral streptococci, and the oral cavity acts as a reservoir in which this exchange occurs; viridans streptococci are in turn considered a source of the altered genes found in pneumococci. Because the mechanism is target alteration rather than enzymatic hydrolysis, beta-lactamase inhibitor combinations confer no advantage.

This is clinically consequential in two settings. In febrile neutropenia, viridans streptococcal bacteraemia can progress rapidly and empirical cover must account for local non-susceptibility rates, particularly where a beta-lactam is used alone. In infective endocarditis, regimens and their duration are stratified by the penicillin minimum inhibitory concentration of the isolate, with fully susceptible organisms treatable by shorter combination courses and less susceptible ones requiring extended therapy or alternative agents, so accurate quantitative testing directly changes patient management. Macrolide resistance is also common, and reduced susceptibility to fluoroquinolones has been described following fluoroquinolone prophylaxis in haematology patients, which limits an agent class that would otherwise be attractive for that population. Vancomycin retains reliable activity and is the usual fallback.

Susceptibility testing of every clinically significant isolate is therefore standard practice, with minimum inhibitory concentrations reported rather than categorical results alone where endocarditis is suspected. None of this bears on reprocessing control. Viridans streptococci exhibit no meaningful tolerance to the biocides or thermal processes used in endoscope, CSD or dental instrument reprocessing, and antimicrobial resistance in an isolate from a water or channel sample does not alter the remediation approach. It may, however, be epidemiologically useful: an unusual resistance pattern shared between a water or scope isolate and a patient isolate strengthens a suspected link and should prompt retention of both isolates for typing.